62921-32-8 Usage
General Description
The chemical compound "(14E,24E)-8-(aminomethyl)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate" is a complex organic molecule with a naphtho[2,1-b]furan structure. It contains multiple hydroxy groups, a methoxy group, and an acetate group, along with a long chain of methyl groups. It also features an aminomethyl group and an epoxide group. The compound is highly functionalized and likely possesses biological activity due to the presence of the aminomethyl and hydroxy groups. Its complex structure and multiple functional groups make it a challenging molecule to synthesize and study.
Check Digit Verification of cas no
The CAS Registry Mumber 62921-32-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,9,2 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 62921-32:
(7*6)+(6*2)+(5*9)+(4*2)+(3*1)+(2*3)+(1*2)=118
118 % 10 = 8
So 62921-32-8 is a valid CAS Registry Number.
62921-32-8Relevant articles and documents
3-N-substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives
McCarthy,Moore,Wysong,Aldrich
, p. 1272 - 1276 (2007/10/21)
A new synthesis of Mannich bases of rifamycin SV using the Borch procedure with rifaldehyde is described. This new synthesis offers two advantages over the previously published method. It provides a route to monoalkyl-aminomethylrifamycins (1e-h) and to unsubstituted aminomethylrifamycins that were not accessible by the old procedure. The new method also offers a preparative route to Mannich bases 1a and 1b which were needed in multigram quantities for biological testing. In addition, the cyclization of certain of the monoalkylaminomethylrifamycins to the novel N,15 didehydro 15 deoxo 3,15 epi[methano(alkylimino)]rifamycin SV derivatives is described. The anticellular and antiviral effects of representatives of both series of compounds against cultured mouse cells and murine oncornavirus are discussed.
